A maestro that conducts the invasiveness of glioblastoma tumors

by Instituto Gulbenkian de CienciaZEB1 is able to simultaneously switch 'on' and 'of' a large number of genes in cancer cells, in this way functioning as a 'conductor' tha

Updated on: April 10,2024

A maestro that conducts the invasiveness of glioblastoma tumors

by Instituto Gulbenkian de CienciaZEB1 is able to simultaneously switch 'on' and 'of' a large number of genes in cancer cells, in this way functioning as a 'conductor' tha

Updated on:April 10,2024

An antenna for detecting breast cancer

by David Bradley,InderscienceCredit: CC0 Public DomainBreast cancer is a common illness around the world. It is the most common invasive of cancers in women and affects around one in eight and r

Updated on: March 30,2024

An antenna for detecting breast cancer

by David Bradley,InderscienceCredit: CC0 Public DomainBreast cancer is a common illness around the world. It is the most common invasive of cancers in women and affects around one in eight and r

Updated on:March 30,2024

Genes activated in metastasis also drive the first stages of tumour growth

by Institute for Research in Biomedicine (IRB Barcelona)The overexpression of the gene Serpent in the Drosophila wing causes permanent overgrowth and it is sufficient to promote tumour developmen

Updated on: March 01,2024

Genes activated in metastasis also drive the first stages of tumour growth

by Institute for Research in Biomedicine (IRB Barcelona)The overexpression of the gene Serpent in the Drosophila wing causes permanent overgrowth and it is sufficient to promote tumour developmen

Updated on:March 01,2024

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res

Updated on: January 02,2024

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res

Updated on:January 02,2024

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred

Updated on: January 02,2024

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred

Updated on:January 02,2024

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a

Updated on: September 27,2024

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a

Updated on:September 27,2024

Expanding LDCT eligibility guidelines would increase number of women and Blacks who benefit from screening

by International Association for the Study of Lung CancerCredit: CC0 Public DomainExpanding the eligibility criteria for low-dose CT (LDCT) screening for lung cancer can increase the number of women a

Updated on: December 28,2023

Expanding LDCT eligibility guidelines would increase number of women and Blacks who benefit from screening

by International Association for the Study of Lung CancerCredit: CC0 Public DomainExpanding the eligibility criteria for low-dose CT (LDCT) screening for lung cancer can increase the number of women a

Updated on:December 28,2023

Sugar molecules as a target in cancer therapy

byUniversity of BaselTherapeutic desialylation repolarizes tumor-associated macrophages (TAMs). (A) Pathway enrichment analysis performed on all macrophages between treatment conditions. UT, unt

Updated on: January 07,2024

Sugar molecules as a target in cancer therapy

byUniversity of BaselTherapeutic desialylation repolarizes tumor-associated macrophages (TAMs). (A) Pathway enrichment analysis performed on all macrophages between treatment conditions. UT, unt

Updated on:January 07,2024

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on: January 04,2024

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on:January 04,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on: January 23,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on:January 23,2024

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (

Updated on: January 04,2024

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (

Updated on:January 04,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on: January 29,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on:January 29,2024